Annual CFI
-$832.00 K
-$11.82 M-107.57%
December 31, 2023
Summary
- As of February 12, 2025, AIM annual cash flow from investing activities is -$832.00 thousand, with the most recent change of -$11.82 million (-107.57%) on December 31, 2023.
- During the last 3 years, AIM annual CFI has risen by +$8.33 million (+90.92%).
- AIM annual CFI is now -103.72% below its all-time high of $22.34 million, reached on December 31, 2013.
Performance
AIM Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$334.00 K
-$492.00 K-59.56%
September 30, 2024
Summary
- As of February 12, 2025, AIM quarterly cash flow from investing activities is $334.00 thousand, with the most recent change of -$492.00 thousand (-59.56%) on September 30, 2024.
- Over the past year, AIM quarterly CFI has increased by +$548.00 thousand (+256.07%).
- AIM quarterly CFI is now -96.40% below its all-time high of $9.27 million, reached on December 31, 2013.
Performance
AIM Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$788.00 K
+$670.00 K+567.80%
September 30, 2024
Summary
- As of February 12, 2025, AIM TTM cash flow from investing activities is $788.00 thousand, with the most recent change of +$670.00 thousand (+567.80%) on September 30, 2024.
- Over the past year, AIM TTM CFI has increased by +$1.62 million (+194.71%).
- AIM TTM CFI is now -96.47% below its all-time high of $22.34 million, reached on December 31, 2013.
Performance
AIM TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
AIM Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -107.6% | +256.1% | +194.7% |
| 3 y3 years | +90.9% | +263.7% | -76.3% |
| 5 y5 years | -1004.4% | +263.7% | -76.3% |
AIM Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -107.6% | at low | -95.7% | +196.5% | -93.0% | +152.5% |
| 5 y | 5-year | -107.6% | +90.9% | -95.7% | +103.5% | -93.0% | +105.5% |
| alltime | all time | -103.7% | +98.1% | -96.4% | +100.8% | -96.5% | +101.7% |
AIM ImmunoTech Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $334.00 K(-59.6%) | $788.00 K(+567.8%) |
| Jun 2024 | - | $826.00 K(-622.8%) | $118.00 K(-112.9%) |
| Mar 2024 | - | -$158.00 K(-26.2%) | -$912.00 K(+9.6%) |
| Dec 2023 | -$832.00 K(-107.6%) | -$214.00 K(-36.3%) | -$832.00 K(-130.3%) |
| Sep 2023 | - | -$336.00 K(+64.7%) | $2.75 M(-17.6%) |
| Jun 2023 | - | -$204.00 K(+161.5%) | $3.33 M(-70.4%) |
| Mar 2023 | - | -$78.00 K(-102.3%) | $11.26 M(+2.4%) |
| Dec 2022 | $10.99 M(-1841.4%) | $3.36 M(+1245.2%) | $10.99 M(+37.5%) |
| Sep 2022 | - | $250.00 K(-96.8%) | $7.99 M(+8.4%) |
| Jun 2022 | - | $7.72 M(-2331.5%) | $7.37 M(-591.5%) |
| Mar 2022 | - | -$346.00 K(-195.1%) | -$1.50 M(+137.7%) |
| Dec 2021 | -$631.00 K(-93.1%) | $364.00 K(-199.5%) | -$631.00 K(-46.4%) |
| Sep 2021 | - | -$366.00 K(-68.2%) | -$1.18 M(-88.7%) |
| Jun 2021 | - | -$1.15 M(-320.3%) | -$10.39 M(-15.7%) |
| Mar 2021 | - | $523.00 K(-387.4%) | -$12.32 M(+34.5%) |
| Dec 2020 | -$9.16 M(+49.1%) | -$182.00 K(-98.1%) | -$9.16 M(-35.8%) |
| Sep 2020 | - | -$9.58 M(+210.9%) | -$14.27 M(+190.1%) |
| Jun 2020 | - | -$3.08 M(-183.7%) | -$4.92 M(+260.2%) |
| Mar 2020 | - | $3.68 M(-169.6%) | -$1.37 M(-77.8%) |
| Dec 2019 | -$6.15 M(-6781.5%) | -$5.29 M(+2179.7%) | -$6.15 M(+158.7%) |
| Sep 2019 | - | -$232.00 K(-149.2%) | -$2.38 M(+55.6%) |
| Jun 2019 | - | $472.00 K(-143.0%) | -$1.53 M(-25.2%) |
| Mar 2019 | - | -$1.10 M(-27.7%) | -$2.04 M(-2319.6%) |
| Dec 2018 | $92.00 K(-96.6%) | -$1.52 M(-346.0%) | $92.00 K(-96.6%) |
| Sep 2018 | - | $617.00 K(-1534.9%) | $2.70 M(+20.4%) |
| Jun 2018 | - | -$43.00 K(-104.2%) | $2.24 M(-31.7%) |
| Mar 2018 | - | $1.04 M(-4.7%) | $3.28 M(+20.1%) |
| Dec 2017 | $2.73 M(-6.4%) | $1.09 M(+579.4%) | $2.73 M(+68.9%) |
| Sep 2017 | - | $160.00 K(-84.0%) | $1.62 M(-43.2%) |
| Jun 2017 | - | $997.00 K(+105.1%) | $2.85 M(-17.8%) |
| Mar 2017 | - | $486.00 K(-1900.0%) | $3.46 M(+18.7%) |
| Dec 2016 | $2.92 M(-54.1%) | -$27.00 K(-101.9%) | $2.92 M(-59.6%) |
| Sep 2016 | - | $1.39 M(-13.8%) | $7.21 M(-12.7%) |
| Jun 2016 | - | $1.61 M(-2788.3%) | $8.26 M(+27.4%) |
| Mar 2016 | - | -$60.00 K(-101.4%) | $6.48 M(+2.1%) |
| Dec 2015 | $6.35 M(+150.9%) | $4.27 M(+75.1%) | $6.35 M(+60.2%) |
| Sep 2015 | - | $2.44 M(-1595.7%) | $3.96 M(+52.6%) |
| Jun 2015 | - | -$163.00 K(-15.1%) | $2.60 M(+3.2%) |
| Mar 2015 | - | -$192.00 K(-110.2%) | $2.52 M(-0.6%) |
| Dec 2014 | $2.53 M(-88.7%) | $1.88 M(+75.6%) | $2.53 M(-74.5%) |
| Sep 2014 | - | $1.07 M(-540.7%) | $9.92 M(-24.6%) |
| Jun 2014 | - | -$243.00 K(+37.3%) | $13.17 M(-22.2%) |
| Mar 2014 | - | -$177.00 K(-101.9%) | $16.92 M(-24.2%) |
| Dec 2013 | $22.34 M(-239.0%) | $9.27 M(+114.8%) | $22.34 M(+982.3%) |
| Sep 2013 | - | $4.32 M(+22.9%) | $2.06 M(-122.3%) |
| Jun 2013 | - | $3.51 M(-33.0%) | -$9.24 M(-25.9%) |
| Mar 2013 | - | $5.24 M(-147.6%) | -$12.47 M(-22.4%) |
| Dec 2012 | -$16.07 M(-285.6%) | -$11.00 M(+57.4%) | -$16.07 M(+362.0%) |
| Sep 2012 | - | -$6.99 M(-2536.6%) | -$3.48 M(-152.8%) |
| Jun 2012 | - | $287.00 K(-82.5%) | $6.59 M(-27.9%) |
| Mar 2012 | - | $1.64 M(+3.7%) | $9.14 M(+5.6%) |
| Dec 2011 | $8.65 M(-119.9%) | $1.58 M(-48.5%) | $8.65 M(-1.4%) |
| Sep 2011 | - | $3.08 M(+8.6%) | $8.78 M(+43.7%) |
| Jun 2011 | - | $2.83 M(+144.5%) | $6.11 M(-115.7%) |
| Mar 2011 | - | $1.16 M(-32.1%) | -$38.94 M(-10.5%) |
| Dec 2010 | -$43.52 M | $1.71 M(+319.7%) | -$43.52 M(-4.5%) |
| Sep 2010 | - | $407.00 K(-101.0%) | -$45.56 M(+1.1%) |
| Jun 2010 | - | -$42.21 M(+1134.6%) | -$45.07 M(+2098.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2010 | - | -$3.42 M(+911.5%) | -$2.05 M(+257.1%) |
| Dec 2009 | -$574.00 K(-115.4%) | -$338.00 K(-137.6%) | -$574.00 K(+78.8%) |
| Sep 2009 | - | $899.00 K(+11.3%) | -$321.00 K(-76.2%) |
| Jun 2009 | - | $808.00 K(-141.6%) | -$1.35 M(-265.8%) |
| Mar 2009 | - | -$1.94 M(+2185.9%) | $814.00 K(-78.2%) |
| Dec 2008 | $3.74 M(-73.2%) | -$85.00 K(-34.6%) | $3.74 M(-64.4%) |
| Sep 2008 | - | -$130.00 K(-104.4%) | $10.48 M(-27.0%) |
| Jun 2008 | - | $2.97 M(+203.6%) | $14.36 M(-14.7%) |
| Mar 2008 | - | $979.00 K(-85.3%) | $16.83 M(+20.6%) |
| Dec 2007 | $13.96 M(-293.7%) | $6.66 M(+77.8%) | $13.96 M(+318.6%) |
| Sep 2007 | - | $3.75 M(-31.2%) | $3.33 M(-15.5%) |
| Jun 2007 | - | $5.44 M(-386.9%) | $3.95 M(-153.2%) |
| Mar 2007 | - | -$1.90 M(-52.1%) | -$7.42 M(+3.0%) |
| Dec 2006 | -$7.21 M(+24.6%) | -$3.96 M(-190.8%) | -$7.21 M(-25.5%) |
| Sep 2006 | - | $4.36 M(-173.6%) | -$9.67 M(-32.1%) |
| Jun 2006 | - | -$5.92 M(+251.6%) | -$14.23 M(+92.5%) |
| Mar 2006 | - | -$1.68 M(-73.8%) | -$7.40 M(+27.9%) |
| Dec 2005 | -$5.78 M(-14.9%) | -$6.42 M(+2987.5%) | -$5.78 M(+333.6%) |
| Sep 2005 | - | -$208.00 K(-122.7%) | -$1.33 M(-39.7%) |
| Jun 2005 | - | $918.00 K(-1375.0%) | -$2.21 M(-46.5%) |
| Mar 2005 | - | -$72.00 K(-96.3%) | -$4.14 M(-39.1%) |
| Dec 2004 | -$6.80 M(+280.3%) | -$1.97 M(+81.4%) | -$6.80 M(+0.3%) |
| Sep 2004 | - | -$1.09 M(+8.2%) | -$6.77 M(+18.8%) |
| Jun 2004 | - | -$1.00 M(-63.2%) | -$5.70 M(+13.6%) |
| Mar 2004 | - | -$2.73 M(+40.1%) | -$5.02 M(+181.0%) |
| Dec 2003 | -$1.79 M(-138.9%) | -$1.95 M(>+9900.0%) | -$1.79 M(-515.6%) |
| Sep 2003 | - | -$17.00 K(-94.7%) | $430.00 K(-79.2%) |
| Jun 2003 | - | -$322.00 K(-164.1%) | $2.06 M(-19.0%) |
| Mar 2003 | - | $502.00 K(+88.0%) | $2.55 M(-44.6%) |
| Dec 2002 | $4.60 M(-599.7%) | $267.00 K(-83.5%) | $4.60 M(+3207.2%) |
| Sep 2002 | - | $1.62 M(+903.7%) | $139.00 K(-137.3%) |
| Jun 2002 | - | $161.00 K(-93.7%) | -$373.00 K(-134.6%) |
| Mar 2002 | - | $2.55 M(-160.9%) | $1.08 M(-217.1%) |
| Dec 2001 | -$920.00 K(-71.6%) | -$4.19 M(-479.6%) | -$920.00 K(-210.1%) |
| Sep 2001 | - | $1.10 M(-31.5%) | $835.60 K(-328.2%) |
| Jun 2001 | - | $1.61 M(+189.7%) | -$366.20 K(-85.0%) |
| Mar 2001 | - | $556.00 K(-122.8%) | -$2.44 M(-24.7%) |
| Dec 2000 | -$3.25 M(+129.3%) | -$2.44 M(+2390.2%) | -$3.25 M(+52.7%) |
| Sep 2000 | - | -$97.80 K(-79.1%) | -$2.12 M(-29.8%) |
| Jun 2000 | - | -$467.80 K(+91.7%) | -$3.03 M(+18.3%) |
| Mar 2000 | - | -$244.00 K(-81.4%) | -$2.56 M(+80.8%) |
| Dec 1999 | -$1.42 M(-32.6%) | -$1.31 M(+31.5%) | -$1.42 M(-21.4%) |
| Sep 1999 | - | -$1.00 M(<-9900.0%) | -$1.80 M(+80.0%) |
| Jun 1999 | - | $0.00(-100.0%) | -$1.00 M(-9.1%) |
| Mar 1999 | - | $900.00 K(-152.9%) | -$1.10 M(-47.6%) |
| Dec 1998 | -$2.10 M(+61.5%) | -$1.70 M(+750.0%) | -$2.10 M(+40.0%) |
| Sep 1998 | - | -$200.00 K(+100.0%) | -$1.50 M(+7.1%) |
| Jun 1998 | - | -$100.00 K(0.0%) | -$1.40 M(0.0%) |
| Mar 1998 | - | -$100.00 K(-90.9%) | -$1.40 M(+7.7%) |
| Dec 1997 | -$1.30 M(+160.0%) | -$1.10 M(+1000.0%) | -$1.30 M(+225.0%) |
| Sep 1997 | - | -$100.00 K(0.0%) | -$400.00 K(-20.0%) |
| Jun 1997 | - | -$100.00 K(<-9900.0%) | -$500.00 K(+25.0%) |
| Mar 1997 | - | $0.00(-100.0%) | -$400.00 K(-20.0%) |
| Dec 1996 | -$500.00 K(+400.0%) | -$200.00 K(0.0%) | -$500.00 K(+66.7%) |
| Sep 1996 | - | -$200.00 K(<-9900.0%) | -$300.00 K(+200.0%) |
| Jun 1996 | - | $0.00(-100.0%) | -$100.00 K(0.0%) |
| Mar 1996 | - | -$100.00 K | -$100.00 K |
| Dec 1995 | -$100.00 K | - | - |
FAQ
- What is AIM ImmunoTech annual cash flow from investing activities?
- What is the all time high annual CFI for AIM ImmunoTech?
- What is AIM ImmunoTech annual CFI year-on-year change?
- What is AIM ImmunoTech quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for AIM ImmunoTech?
- What is AIM ImmunoTech quarterly CFI year-on-year change?
- What is AIM ImmunoTech TTM cash flow from investing activities?
- What is the all time high TTM CFI for AIM ImmunoTech?
- What is AIM ImmunoTech TTM CFI year-on-year change?
What is AIM ImmunoTech annual cash flow from investing activities?
The current annual CFI of AIM is -$832.00 K
What is the all time high annual CFI for AIM ImmunoTech?
AIM ImmunoTech all-time high annual cash flow from investing activities is $22.34 M
What is AIM ImmunoTech annual CFI year-on-year change?
Over the past year, AIM annual cash flow from investing activities has changed by -$11.82 M (-107.57%)
What is AIM ImmunoTech quarterly cash flow from investing activities?
The current quarterly CFI of AIM is $334.00 K
What is the all time high quarterly CFI for AIM ImmunoTech?
AIM ImmunoTech all-time high quarterly cash flow from investing activities is $9.27 M
What is AIM ImmunoTech quarterly CFI year-on-year change?
Over the past year, AIM quarterly cash flow from investing activities has changed by +$548.00 K (+256.07%)
What is AIM ImmunoTech TTM cash flow from investing activities?
The current TTM CFI of AIM is $788.00 K
What is the all time high TTM CFI for AIM ImmunoTech?
AIM ImmunoTech all-time high TTM cash flow from investing activities is $22.34 M
What is AIM ImmunoTech TTM CFI year-on-year change?
Over the past year, AIM TTM cash flow from investing activities has changed by +$1.62 M (+194.71%)